COMPOSITION FOR PREVENTING AND TREATING ASTHMA, CONTAINING BENZOFURAN-BASED COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT
The present invention relates to a composition for preventing and treating asthma, containing a benzofuran compound or a pharmaceutically acceptable salt thereof as an active ingredient, and the benzofuran compound of the present invention effectively inhibits airway hyperresponsiveness and the infi...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a composition for preventing and treating asthma, containing a benzofuran compound or a pharmaceutically acceptable salt thereof as an active ingredient, and the benzofuran compound of the present invention effectively inhibits airway hyperresponsiveness and the infiltration of inflammatory cells which are caused by asthma, regulates Th2 immune response so as to inhibit the generation of cytokines (interleukins-4, -5 and -13) secreted thereby, remarkably reduces the generation of blood serum IgE and ovalbumin-specific IgE, and significantly decreases inflammatory cells in bronchoalveolar lavage fluid, and thus can be useful in the prevention and treatment of inflammatory diseases including asthma or inflammatory lung diseases.
La présente invention concerne une composition pour la prévention et le traitement de l'asthme, contenant en tant qu'ingrédient actif un composé benzofurane ou un sel pharmaceutiquement acceptable de ce dernier. Le composé benzofurane de la présente invention inhibe efficacement l'hyperréactivité des voies aériennes et l'infiltration de cellules inflammatoires causées par l'asthme, régule la réponse immunitaire Th2 et ainsi inhibe la production de cytokines (interleukines -4, -5 et -13) secrétées lors de cette réponse, diminue de façon marquée la production d'IgE sérique et de l'IgE spécifique de l'ovalbumine, et diminue de manière significative la quantité de cellules inflammatoires dans le fluide de lavage broncho-alvéolaire, et peut donc être utile dans la prévention et le traitement de maladies inflammatoires, dont l'asthme ou les maladies pulmonaires inflammatoires.
본 발명은 벤조퓨란계(benzofuran) 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 천식 예방 및 치료용 조성물에 관한 것으로, 본 발명의 벤조퓨란계(benzofuran) 화합물은 천식으로 유발된 기도과민성 및 염증세포의 침윤을 효과적으로 억제하고, Th2 타입의 면역반응을 조절하여 이로 인해 분비되는 사이토카인(인터루킨-4, -5, -13)의 생성을 억제하며, 혈청 내 IgE와 난백알부민 특이 IgE의 생성을 현저하게 감소시키고, 기관지 폐포세척액 내 염증세포를 유의적으로 감소시키므로, 천식 또는 염증성 폐질환을 포함하는 염증성 질환 예방 및 치료에 유용하게 사용될 수 있다. |
---|